eIF4E inhibition exhibits anti-tumor activity and re-sensitizes acquired resistant KRASG12C NSCLC to KRAS inhibitors View Poster ESMO Congress 2024 Barcelona Spain, 13-17 September 2024
Development of novel eIF4E inhibitors to potently and selectively suppress tumor growth across multiple indications View Poster American Association of Cancer Research Annual Meeting 2024 San Diego, April 7, 2024
Leveraging an RNA-targeting platform for the discovery of cell-active c-MYC mRNA-binding small molecules View Poster American Association of Cancer Research Annual Meeting 2024 San Diego, April 7, 2024
Pharmacological eIF4E inhibition drives anti-tumor activity in ER+ breast cancer View Poster 2023 San Antonio Breast Cancer Symposium San Antonio, December 5-9, 2023
EIF4E inhibition drives anti-tumor activity in BRAFV600E melanoma View Poster Society for Melanoma Research Congress Philadelphia, November 6-9, 2023
